Low-molecular-weight heparin versus oral anticoagulant therapy for the long-term treatment of symptomatic venous thromboembolism: Is there any difference in cancer-related mortality?
Ferretti
Gianluigi
G
Bria
Emilio
E
Giannarelli
Diana
D
Carlini
Paolo
P
Felici
Alessandra
A
Mandala
Mario
M
Papaldo
Paolo
P
Nistico
Cecilia
C
Fabi
Alessandra
A
Cuppone
Federica
F
Gelibter
Alain
A
Terzoli
Edmondo
E
Cognetti
Francesco
F
D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D015897:Comorbidity; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000401:mortality*; D016032:Randomized Controlled Trials as Topic; D016019:Survival Analysis; D013923:Thromboembolism / Q000517:prevention & control*; D020246:Venous Thrombosis / Q000517:prevention & control*
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight